UGT1A7

UDP glucuronosyltransferase family 1 member A7, the group of UDP glucuronosyltransferases

Basic information

Region (hg38): 2:233681901-233773300

Links

ENSG00000244122NCBI:54577OMIM:606432HGNC:12539Uniprot:Q9HAW7AlphaFoldGenCCjaxSfariGnomADPubmedClinVar

Phenotypes

GenCC

Source: genCC

No genCC data.

ClinVar

This is a list of variants' phenotypes submitted to ClinVar and linked to the UGT1A7 gene.

  • not provided (22 variants)
  • Crigler-Najjar syndrome type 1 (6 variants)
  • Crigler-Najjar syndrome (4 variants)
  • UGT1A1-related disorder (4 variants)
  • Hyperbilirubinemia (2 variants)
  • Gilbert syndrome (2 variants)
  • Crigler-Najjar syndrome, type II (2 variants)
  • Crigler-Najjar syndrome type 1;Gilbert syndrome;Crigler-Najjar syndrome, type II;Lucey-Driscoll syndrome (1 variants)

Variants pathogenicity by type

Statistics on ClinVar variants can assist in determining whether a specific variant type in the UGT1A7 gene is commonly pathogenic or not.

In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.

Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.

Variant type Pathogenic Likely pathogenic VUS Likely benign Benign Sum
synonymous
5
clinvar
20
clinvar
3
clinvar
28
missense
2
clinvar
9
clinvar
85
clinvar
7
clinvar
4
clinvar
107
nonsense
4
clinvar
5
clinvar
9
start loss
0
frameshift
4
clinvar
2
clinvar
6
inframe indel
2
clinvar
2
splice donor/acceptor (+/-2bp)
1
clinvar
3
clinvar
4
splice region
2
1
3
non coding
15
clinvar
11
clinvar
157
clinvar
41
clinvar
23
clinvar
247
Total 26 23 256 68 30

Highest pathogenic variant AF is 0.0000919

Variants in UGT1A7

This is a list of pathogenic ClinVar variants found in the UGT1A7 region.

You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.

Position Type Phenotype Significance ClinVar
2-233681970-C-A Benign (Nov 30, 2023)440385
2-233682005-C-A not specified Uncertain significance (May 09, 2022)2288007
2-233682041-G-A not specified Uncertain significance (Dec 08, 2023)3186116
2-233682060-G-A not specified Uncertain significance (Nov 30, 2018)811843
2-233682109-G-T not specified Uncertain significance (Jun 22, 2021)2348238
2-233682129-G-A Uncertain significance (Mar 27, 2023)2690427
2-233682180-C-A Uncertain significance (Dec 20, 2023)2690429
2-233682199-C-T Uncertain significance (Feb 22, 2020)993651
2-233682205-T-C not specified Uncertain significance (May 01, 2019)811972
2-233682211-G-A not specified Uncertain significance (Oct 05, 2023)3186117
2-233682220-G-A not specified Likely benign (Sep 17, 2021)2252023
2-233682278-A-G Uncertain significance (Dec 23, 2022)2920843
2-233682280-G-A Likely benign (Jul 26, 2023)1679510
2-233682289-G-T Uncertain significance (Jun 27, 2018)618470
2-233682301-T-C not specified Uncertain significance (Aug 09, 2021)2241508
2-233682323-A-G Likely benign (Nov 30, 2023)1330729
2-233682323-AT-GG Likely benign (Nov 30, 2023)1330751
2-233682324-T-G Benign (Nov 30, 2023)440386
2-233682328-C-A Benign (Nov 30, 2023)440387
2-233682328-CG-AA Benign (Nov 30, 2023)1333166
2-233682329-G-A Benign (Nov 30, 2023)440388
2-233682354-G-C Likely benign (Sep 14, 2023)1330505
2-233682359-G-C Uncertain significance (Jul 02, 2021)1330921
2-233682404-T-C not specified Uncertain significance (Feb 28, 2023)2466343
2-233682412-A-G not specified Uncertain significance (Mar 01, 2024)3186118

GnomAD

Source: gnomAD

GeneTypeBio TypeTranscript Coding Exons Length
UGT1A7protein_codingprotein_codingENST00000373426 591362
pLI Probability
LOF Intolerant
pRec Probability
LOF Recessive
Individuals with
no LOFs
Individuals with
Homozygous LOFs
Individuals with
Heterozygous LOFs
Defined p
8.66e-140.019512553702111257480.000839
Z-Score Observed Expected Observed/Expected Mutation Rate Total Possible in Transcript
Missense-0.4113142941.070.00001733463
Missense in Polyphen142135.351.04921605
Synonymous-2.561501151.300.000007261049
Loss of Function-0.03162019.81.010.00000118237

LoF frequencies by population

EthnicitySum of pLOFs p
African & African-American0.005850.00586
Ashkenazi Jewish0.000.00
East Asian0.0005440.000544
Finnish0.0006470.000647
European (Non-Finnish)0.0005500.000545
Middle Eastern0.0005440.000544
South Asian0.0006210.000621
Other0.0003260.000326

dbNSFP

Source: dbNSFP

Function
FUNCTION: UDPGT is of major importance in the conjugation and subsequent elimination of potentially toxic xenobiotics and endogenous compounds. Isoform 2 lacks transferase activity but acts as a negative regulator of isoform 1. {ECO:0000269|PubMed:23360619}.;
Pathway
Retinol metabolism - Homo sapiens (human);Steroid hormone biosynthesis - Homo sapiens (human);Metabolism of xenobiotics by cytochrome P450 - Homo sapiens (human);Drug metabolism - other enzymes - Homo sapiens (human);Drug metabolism - cytochrome P450 - Homo sapiens (human);Porphyrin and chlorophyll metabolism - Homo sapiens (human);Chemical carcinogenesis - Homo sapiens (human);Ascorbate and aldarate metabolism - Homo sapiens (human);Pentose and glucuronate interconversions - Homo sapiens (human);Mycophenolic acid Pathway, Pharmacokinetics;Mycophenolic acid Pathway, Pharmacokinetics/Pharmacodynamics;Mycophenolic Acid Metabolism Pathway;Aryl Hydrocarbon Receptor Pathway;Nuclear Receptors Meta-Pathway;NRF2 pathway;Glucuronidation;Metapathway biotransformation Phase I and II;Glucuronidation;Phase II - Conjugation of compounds;Tyrosine metabolism;Androgen and estrogen biosynthesis and metabolism;Biological oxidations;Metabolism;Linoleate metabolism;Vitamin A (retinol) metabolism;Xenobiotics metabolism;Porphyrin metabolism (Consensus)

Recessive Scores

pRec
0.581

Intolerance Scores

loftool
0.989
rvis_EVS
-0.15
rvis_percentile_EVS
42.23

Haploinsufficiency Scores

pHI
hipred
N
hipred_score
0.112
ghis
0.394

Essentials

essential_gene_CRISPR
N
essential_gene_CRISPR2
essential_gene_gene_trap
N
gene_indispensability_pred
N
gene_indispensability_score
0.0472

Gene Damage Prediction

AllRecessiveDominant
MendelianMediumMediumMedium
Primary ImmunodeficiencyMediumMediumMedium
CancerMediumMediumMedium

Mouse Genome Informatics

Gene name
Ugt1a9
Phenotype

Gene ontology

Biological process
excretion;coumarin metabolic process;drug metabolic process;retinoic acid metabolic process;negative regulation of catalytic activity;flavone metabolic process;cellular glucuronidation;flavonoid glucuronidation;xenobiotic glucuronidation
Cellular component
endoplasmic reticulum;endoplasmic reticulum membrane;integral component of membrane;intracellular membrane-bounded organelle
Molecular function
retinoic acid binding;enzyme inhibitor activity;protein kinase C binding;UDP-glycosyltransferase activity;glucuronosyltransferase activity;protein homodimerization activity;protein heterodimerization activity